These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2339088)

  • 1. Principles and mechanisms of receptor studies.
    Herzog H
    Nuklearmedizin; 1990 Mar; 29(2):81. PubMed ID: 2339088
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptor imaging in alcohol dependency: should personality traits be taken into account?
    Goethals I; Van De Wiele C; Audenaert K
    Eur J Nucl Med; 2001 Nov; 28(11):1585-8. PubMed ID: 11702097
    [No Abstract]   [Full Text] [Related]  

  • 3. SPECT imaging of dopamine receptors.
    Ichise M; Ballinger JR
    J Nucl Med; 1996 Oct; 37(10):1591-5. PubMed ID: 8862289
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron emission tomography imaging of dopamine and serotonin receptors in Huntington's chorea.
    Wong DF; Wagner HN; Links JM; Dannals RF; Folstein S; Ravert HT; Tune L; Pearlson G; Frost JJ; Folstein M
    Am J Physiol Imaging; 1988; 3(1):51. PubMed ID: 2968808
    [No Abstract]   [Full Text] [Related]  

  • 5. [Imaging of D2 dopamine receptor].
    Hatazawa J; Itoh M; Ido T
    Nihon Rinsho; 1991 Jul; 49(7):1546-50. PubMed ID: 1832197
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine receptor classification, neuroanatomical distribution and in vivo imaging.
    Brücke T; Wenger S; Podreka I; Asenbaum S
    Wien Klin Wochenschr; 1991; 103(21):639-46. PubMed ID: 1771898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.
    Kung HF; Alavi A; Chang W; Kung MP; Keyes JW; Velchik MG; Billings J; Pan S; Noto R; Rausch
    J Nucl Med; 1990 May; 31(5):573-9. PubMed ID: 2140408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Receptors in positron emission tomography].
    Suehiro M
    No To Shinkei; 1982 Sep; 34(9):853-62. PubMed ID: 6291562
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain.
    Wang GJ; Volkow ND; Fowler JS; Wolf AP; MacGregor RR; Shea CE; Schlyer DJ; Hitzemann RJ
    Synapse; 1993 Nov; 15(3):246-9. PubMed ID: 8278901
    [No Abstract]   [Full Text] [Related]  

  • 10. Positron emission tomography studies of neurotransmitter systems.
    Sawle GV; Brooks DJ
    J Neurol; 1990 Dec; 237(8):451-6. PubMed ID: 1981574
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre-synaptic and post-synaptic dopaminergic system in human brain.
    Leenders KL; Herold S; Brooks DJ; Palmer AJ; Turton D; Firnau G; Garnett ES; Nahmias C; Veall N
    Lancet; 1984 Jul; 2(8394):110-1. PubMed ID: 6146002
    [No Abstract]   [Full Text] [Related]  

  • 12. [Positron emission tomography studies of dopamine D1 receptors].
    Shinotoh H
    Nihon Rinsho; 1991 Jul; 49(7):1541-5. PubMed ID: 1832196
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55.
    Shaya EK; Scheffel U; Dannals RF; Ricaurte GA; Carroll FI; Wagner HN; Kuhar MJ; Wong DF
    Synapse; 1992 Feb; 10(2):169-72. PubMed ID: 1585258
    [No Abstract]   [Full Text] [Related]  

  • 14. Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson's disease.
    Rinne JO; Laihinen A; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():152. PubMed ID: 1666760
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.
    Laihinen A; Rinne JO; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():151. PubMed ID: 1666759
    [No Abstract]   [Full Text] [Related]  

  • 16. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
    Schwarz J; Tatsch K; Vogl T; Kirsch CM; Trenkwalder C; Arnold G; Gasser T; Oertel WH
    Mov Disord; 1992; 7(1):58-61. PubMed ID: 1532631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of radiobrominated p-bromospiroperidol for gamma-ray imaging of dopamine receptors.
    Friedman AM; Huang CC; Kulmala HA; Dinerstein R; Navone J; Brunsden B; Gawlas D; Cooper M
    Int J Nucl Med Biol; 1982; 9(1):57-61. PubMed ID: 6979525
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview of radiopharmaceuticals for diagnosis of central nervous disorders.
    Kung HF
    Crit Rev Clin Lab Sci; 1991; 28(4):269-86. PubMed ID: 1930679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (3-N-[11C]methyl)spiperone, a ligand binding to dopamine receptors: radiochemical synthesis and biodistribution studies in mice.
    Burns HD; Dannals RF; Langström B; Ravert HT; Zemyan SE; Duelfer T; Wong DF; Frost JJ; Kuhar MJ; Wagner HN
    J Nucl Med; 1984 Nov; 25(11):1222-7. PubMed ID: 6333496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides.
    Kessler RM; Ansari MS; de Paulis T; Schmidt DE; Clanton JA; Smith HE; Manning RG; Gillespie D; Ebert MH
    J Nucl Med; 1991 Aug; 32(8):1593-600. PubMed ID: 1831229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.